Osteosynthesis Devices Market Size, Share & Trends Analysis Report By Type (Internal, External), By Material, By Fracture Type (Skull, Facial Bones), By Region, And Segment Forecasts, 2023 - 2030

Osteosynthesis Devices Market Size, Share & Trends Analysis Report By Type (Internal, External), By Material, By Fracture Type (Skull, Facial Bones), By Region, And Segment Forecasts, 2023 - 2030

Osteosynthesis Devices Market Growth & Trends

The global osteosynthesis devices market size is anticipated to reach USD 17.2 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 8.2% from 2023 to 2030. The increasing prevalence of osteoporosis among the aging population, rising product innovation, and expanding product adoption by end users are the main factors fueling the market's expansion.

Other factors driving the market growth during the forecast period include the rising prevalence of proximal fractures in the elderly, the complexity of fractures, and the way the patient's comorbidities affect treatment management. Furthermore, the quick transition to noninvasive osteosynthesis technology demonstrates the growing potential for market growth.

Moreover, orthopedic surgery conditions including fracture repair and arthroplasty are being treated surgically more extensively. Orthopedic implants are used to treat significant fractures that need realignment and fixation for appropriate healing as well as bone defects that cannot be repaired. Furthermore, it is anticipated that as orthopedic treatments grow more common, the demand for connected devices implanted in the bone to support materials would rise in the future.

Companies have been focusing on improving the factors which could provide winning capabilities, whether internally or outside through collaborations, in order to compete in a world where value-based care is the trend. Major market players are therefore being forced to work together, make acquisitions, and create new goods, that are all anticipated to fuel market expansion in the future years. For instance, DePuy Synthes, Inc. (J & J Company), bought CrossRoads in February 2022; this acquisition will fuel its advancements in orthopedic, pediatric, and Medtech through both internal and external innovation. Furthermore, in March 2022, Life Spine received FDA 510k approval for its SImpact Si Joint Fixation System for Posterior-Oblique approaches.

Osteosynthesis Devices Market Report Highlights

• The osteosynthesis devices market was valued at USD 9.2 billion in 2022 and is expected to expand at a CAGR of 8.2% during the forecast period
• Based on the type, the market is categorized into internal devices and external devices. The Internal devices segment dominated the market by type in 2022, this segment is anticipated to maintain its leading position from 2022 to 2030, owing to the growing volume of bone fracture surgeries
• Based on material, the market is segmented into degradable and non-degradable. The non-degradable segment held the largest market share of over 81% in 2022. However, problems pertaining to their usage (titanium and stainless steel) have raised the risk of infection and metallosis, or metal poisoning, which has led to a rise in the use of absorbable and biocompatible internal bone fixation devices
• Patella, tibia or fibula, or ankle held the largest market share by fracture type in 2022, owing to the increasing prevalence of ankle, patella, and tibia fracture conditions
• North America held the largest market share of over 52% in 2022. This is a result of the well-established healthcare system, and rising per capita healthcare spending